Southport Management, L.L.C. Immuneering Corp Transaction History
Southport Management, L.L.C.
- $26.9 Billion
- Q3 2024
A detailed history of Southport Management, L.L.C. transactions in Immuneering Corp stock. As of the latest transaction made, Southport Management, L.L.C. holds 205,000 shares of IMRX stock, worth $483,800. This represents 1.9% of its overall portfolio holdings.
Number of Shares
205,000
Previous 160,100
28.04%
Holding current value
$483,800
Previous $205 Million
149.09%
% of portfolio
1.9%
Previous 0.92%
Shares
4 transactions
Others Institutions Holding IMRX
# of Institutions
41Shares Held
4.64MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.53 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.91 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$1.06 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$581,1970.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $62.3M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...